Patients
Get in Touch
For Medical Information inquiries or Adverse Events/Product Complaints reporting, please reach out through our contact page.
Our Clinical Studies
Denali is currently conducting several clinical studies to develop therapeutics for neurodegenerative diseases, lysosomal storage disorders and other serious diseases.
Grants &
Sponsorships
Our Grants & Sponsorships program provides financial support for independent medical education and to nonprofit organizations and patient advocacy groups.
Early Access
Program
An early access program (EAP), also sometimes referred to as expanded access, is a mechanism that allows patients with serious or life-threatening conditions to access investigational drugs or treatments before they are officially approved by regulatory bodies like the FDA or EMA.